Assessing pharmacological interventions for bone metastases: the need for more patient-centered outcomes

JA Ford, G Mowatt, R Jones - Expert Review of Clinical …, 2012 - Taylor & Francis
Bone metastases are associated with a broad spectrum of clinical sequelae. Pain, reduced
mobility, skeletal complications and treatment-related events reduce quality of life …

Assessment of therapeutic response through clinical assessment measures

C Roy, CL Addison, S Mazzarello, I Kuchuk… - Bone Metastases: A …, 2014 - Springer
Bone metastases from advanced stage cancers are common. They pose a significant added
burden on both the patient and the health care system as a whole. There has been …

Emerging therapies in metastatic bone pain

F Coluzzi, I Mandatori, C Mattia - Expert Opinion on Emerging …, 2011 - Taylor & Francis
Introduction: Current treatment for metastatic bone pain is mainly palliative. Recent insights
into the molecular mechanisms involved in bone metastases have led to the identification of …

[HTML][HTML] Rethinking end-points for bone-targeted therapy in advanced cancer

SG García, M Clemons, E Amir - European Journal of Cancer, 2016 - Elsevier
The principal objective for any medical therapy is to improve either the duration of life and/or
its quality. Metastases in bone can lead to clinically defined events termed skeletal-related …

[HTML][HTML] The evolution and understanding of skeletal complication endpoints in clinical trials of tumors with metastasis to the bone

A Hussain, RJ Lee, JN Graff, S Halabi - Critical reviews in oncology …, 2019 - Elsevier
Bone metastases are a frequent complication of solid tumors, leading to significant skeletal
sequelae that negatively impact quality of life and survival. Prevention and management of …

Future treatment of bone metastases

A Lipton - Clinical Cancer Research, 2006 - AACR
All bone surfaces are periodically remodeled by the coupled and balanced action of
osteoclasts and osteoblasts, of which the activities are regulated by a variety of cytokines …

[HTML][HTML] Skeletal morbidity rates over time in patients with bone metastases from solid tumors reported in bone modifying agents randomised trials

M Poon, L Zeng, L Zhang, M Popovic, R Chow… - Journal of bone …, 2012 - Elsevier
Abstract Objective Skeletal related events (SREs) are common in patients with bone
metastases and lead to decreased quality of life and functional status. The definition of an …

A Comprehensive Review of Interventional Clinical Trials in Patients with Bone Metastases

F Shen, J Huang, K Yang, C Sun - OncoTargets and Therapy, 2023 - Taylor & Francis
Bone metastasis is one of the most important factors associated with poor prognosis for
patients with prostate, breast, thyroid, and lung cancer. In the past two decades, 651 clinical …

Therapeutic strategies for treating osteolytic bone metastases

E Verron, H Schmid-Antomarchi… - Drug discovery today, 2014 - Elsevier
Highlights•Increased incidence of bone metastases requires adapted therapeutic
strategies.•Therapeutic objectives: relieve severe pain and improve the functional …

Current and future treatments of bone metastases

JCM Clark, CR Dass, PFM Choong - Expert Opinion on Emerging …, 2008 - Taylor & Francis
Bone metastases contribute to a significant degree of morbidity in patients with common
cancers through the development of skeletal related events (SRE) such as bone pain and …